Is there a Distinct Phenotype to Memory Loss in Alzheimer's Disease?
|
|
|
- Stanley Arnold
- 9 years ago
- Views:
Transcription
1 Is there a Distinct Phenotype to Memory Loss in Alzheimer's Disease? David A. Wolk, M.D. Assistant Director Penn Memory Center Assistant Professor of Neurology University of Pennsylvania
2 5 Million
3 Clinical and Pathological Course of AD Clinical State Normal Pre-Clinical AD Cognitive No No Symptoms State Symptoms? Pathologic State No Disease Plaques Early Changes MCI Mild Symptoms y p Mild-ModMod Changes AD Mild-Severe Symptoms y p Mod-Severe Changes Tangles
4 Aging Versus AD
5 Age Associated Cognitive Impairment Park and Reuter Lorenz, Ann Rev. Psychol., 2009
6 Aging Versus Preclinical/Prodromal AD Quantitative differences E.g. Face name memory test Specificity dependent of degree of age related and AD related change Qualitative differences?
7 Topographic p Selectivity of AD Mesulam, 1990
8 Braak & Braak. Acta Neuropath, 1991
9 Doctor Who
10 Downton Abbey Sir Richard Carlisle (Ian Glenn)
11 Dual Process Models of Recognition Memory Two distinct memory processes Familiarity (item memory) Acontextual sense of prior encounter Quantitative Relatively automatic process Recollection (associative, relational) Detailed retrieval, including spatial and temporal context mental time travel Qualitative Controlled Process
12 Proposed Spatial and Temporal Dissociation of Recollection and Familiarity it Neuroanatomy Recollection: Hippocampus, Frontal control networks Familiarity: Perirhinal cortex/lateral entorhinal area Timing Recollection: Slower Familiarity: Faster
13 Binding of Items and Context Model Eichenbaum et al., Ann Rev Neurosci, 2007
14 What Drives Memory Loss with Normal Aging? Buckner, Neuron, 2004 Small et al., Nature Neuroscience, 2012
15 Is Familiarity Selectively Impaired in MCI (prodromal lad)? Normal aging: g recollection impaired, familiarity intact MCI: Predict familiarity (and recollection) should be impaired Alternative: If familiarity and recollection on strength continuum, expect relative sparing of familiarity
16 16 MCI; 21 Controls Three process estimation paradigms Wolk et al., Neuropsychologia, 2008
17 Process-Dissociation Paradigms Intact OLD Rearranged NEW Novel NEW pr = p( Old Intact) p( Old Rearranged) pf = p( Old Rearranged)/(1 pr)
18 Wolk et al., Neuropsychologia, 2008
19 Recollection and Familiarity Impaired in MCI (NC: n=81; MCI: n=65) Recollection Familiarity p< p< Control-Referenced z-scores p<0.001 Wolk et al., Neuropsychologia, 2013
20 Is Familiarity Spared in Normal Aging? (YC: n=18; OC: n=81) Recollection p < Familiarity Wolk et al., Neuropsychologia, 2013
21 Petersen Criteria for MCI (now referred dto as amnestic MCI) Memory complaint (preferably corroborated by informant) Episodic Memory impairment for age and education Largely intact general cognitive function Essentially preserved activities of daily living Do not meet criteria for dementia
22 Amnestic MCI Enriched in patients with AD pathology Specialty Clinics 10 to 15% Conversion to clinical AD per year 1 3% in cognitively normal adults 50 80% over 5 years Community Studies (PAQUID, MoVIES) Lower conversion rate (4 to 8%/year) Reversion to normal (10 to 40% over 2 years)
23 Amyloid Imaging 55-65% PiB positive in most studies of MCI Wolk and Klunk, 2009
24 Does Familiarity Discriminates MCI Based on Amyloid Status (n=22)? Recollection Familiarity p<0.05
25 Limited Neuropsychological py Data Familiarity Recollection Rugg and Yonelinas, TICS, 2002 Bowles et al., PNAS, 2007 Guedj et al., Neuropsychologia, 2010
26 Relationship to MTL Volumes Examined relationship of recollection and familiarity estimates with structure Hippocampus Extrahippocampal MTL (PRC, ERC, PHG) Automated Labeling Pathway (Wu et al., 2006; Andreescu et al., 2007) Wolk et al., Hippocampus, 2011
27 * * Wolk et al., Hippocampus, 2011
28 Correlates of Memory in AD Patients from ADNI ADNI participants with clinical AD diagnosis Mean MMSE: 23.3 ±2.0 (SD) MRI of sufficient quality (n=146) MRI analysis Disease specific ROI s (hippocampus, PRC/ERC) Correlate with standard memory measures differentially dependent on recollection/familiarity
29 Memory Measure Rey Auditory Verbal Learning Test (AVLT) 15 words 5 Immediate memory (learning) trials List B immediate memory 5 minute delayed recall 30 minute delayed recall Recognition memory test
30 AD Cohort from ADNI (n=146) AVLT Delayed Memory Measures Recollection Recall ** ** Familiarity Recollection Recognition * Wolk & Dickerson, NeuroImage, 2011
31 Pure Familiarity Recognition discrimination controlled for free recall Wolk and Dickerson, NeuroImage, 2011
32 Interim Summary Familiarity-based memory is spared as part of normal age-associated cognitive decline Familiarity is dependent on integrity of perirhinal cortex (ERC?) Consistent with early involvement of PRC in AD pathologic process, familiarity-based memory appears sensitive and specific to prodromal AD Is familiarity-based memory sensitive to preclinical AD?
33 Preclinical Alzheimer s Disease 25-30% of CN adults with AD molecular biomarker profile Consistent t with autopsy data Morris et al., Annals of Neurology, 2010
34 Cortical Signature of AD Dickerson et al., Cerebral Cortex, 2011
35 Abnormal Amyloid (PiB) Function Psychometrics Biomar rker Magnit tude Normal Normal Presymptomatic MCI Dementia Clinical disease stage Modified from Jack et al., 2010
36 Abnormal Amyloid (PiB) Function Biomar rker Magnit tude Psychometrics Brain Structure (MRI) Normal Normal Presymptomatic MCI Dementia Clinical disease stage Modified from Jack et al., 2010
37 Abnormal Amyloid (PiB) Function Biomar rker Magnit tude Psychometrics Brain Structure (MRI) Brain Physiology (PET) Normal Normal Presymptomatic MCI Dementia Clinical disease stage Modified from Jack et al., 2010
38 Does Evidence of AD Specific Atrophy Predict tdecline in CN Adults ADNI healthy controls with adequate 1.5 T MRI (n=159) Mean AD signature measure converted to z score > 1 SD bl below mean ADsig hi thin (high h risk ik group) Within 1 SD of mean ADsig Average > 1 SD above mean ADsig thick (lowest risk group) 3 year follow up a priori cutoffs of functional (> 1.0 increase in CDR Sum of Boxes) and cognitive decline (> 1 SD decline)
39 Cortical Thinning in Signature of AD regions predicts decline and CSF AD profile in Cognitively Normal Adults Dickerson and Wolk, Neurology, 2012
40 Relationship of AD Cortical Signature with Recollection/Familiarity β=.55, p< β=.37, p< 0.05 Wolk et al., Neuropsychologia, 2013
41 Summary Biomarkers of neurodegeneration may be valuable in temporal prediction in preclinical phases beyond amyloid status Preclinical disease may be associated with subtle cognitive change Familiarity as possible screening measure? Familiarity as cognitive outcome measure in preclinical trials
42 Collaborators Penn Paul Yushkevich Sandy Das MGH/Harvard Pitt Brad Dickerson John Detre Steve Arnold Steve DeKosky Lauren Mancuso Howard Aizenstein Dasha Kliot Eric Signoff Kti Katie Manning Kathryn Dunfee Funding: K23AG028018; R01AG040271; P30AG010124; Alzheimer s Association
Primary Endpoints in Alzheimer s Dementia
Primary Endpoints in Alzheimer s Dementia Dr. Karl Broich Federal Institute for Drugs and Medical Devices (BfArM) Kurt-Georg-Kiesinger-Allee 38, D-53175 Bonn Germany Critique on Regulatory Decisions in
CRITERIA FOR AD DEMENTIA June 11, 2010
CRITERIA F AD DEMENTIA June 11, 2010 Alzheimer s Disease Dementia Workgroup Guy McKhann, Johns Hopkins University (Chair) Bradley Hyman, Massachusetts General Hospital Clifford Jack, Mayo Clinic Rochester
Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych.
Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych. Community Geriatric Mental Health Model of Continuum of Cognition with Aging Normal Mild cognitive
Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment
Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate
Biomarkers for Alzheimer's Disease in Down Syndrome
Biomarkers for Alzheimer's Disease in Down Syndrome Brad Christian, Ph.D. Waisman Laboratory for Brain Imaging Outline Rationale for Studying AD in Down Syndrome Background of Alzheimer s Disease Biomarkers
MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease
MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease Outline of Today s Lecture Why is Alzheimer s disease a problem? What is Alzheimer s Disease? What causes Alzheimer s disease? How can
Clinical Features of Mild Cognitive Impairment and Dementia in a Community: An update of the Osaki-Tajiri Project
Tohoku J. Exp. Med., 2008, 215, 125-131 MCI and Dementia in a Community 125 Review Clinical Features of Mild Cognitive Impairment and Dementia in a Community: An update of the Osaki-Tajiri Project KENICHI
Diseases of the Nervous System. Neal G. Simon, Ph.D. Professor, Dept of Biological Sciences Lehigh University
Diseases of the Nervous System Neal G. Simon, Ph.D. Professor, Dept of Biological Sciences Lehigh University Outline A. Stress-related Disorders 1. Emotional Circuitry: Key Components 2. The Hypothalamic
Current Industry Neuroimaging Experience in Clinical Trials Jerome Barakos, M.D.
Current Industry Neuroimaging Experience in Clinical Trials Jerome Barakos, M.D. Melbourne Australia March 28, 2012 Synarc Experience and Expertise Largest imaging service provider dedicated to clinical
Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI)
Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI) Mike R. Schoenberg, PhD, ABPP-CN Diplomate, American Board of Clinical Neuropsychology Licensed Psychologist Departments of Psychiatry
Human recognition memory: a cognitive neuroscience perspective
Review TRENDS in Cognitive Sciences Vol.7 No.7 July 2003 313 Human recognition memory: a cognitive neuroscience perspective Michael D. Rugg 1 and Andrew P. Yonelinas 2 1 Institute of Cognitive Neuroscience
2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease
2012 Medical School for Actuaries Nov. 6-7, 2012 Session #1: Alzheimer s Disease Dylan Wint, M.D. ALZHEIMER DISEASE Dylan Wint, M.D. Lou Ruvo Center for Brain Health DEFINITIONS Cognitive related to thinking,
Cognitive Interventions for Mild Cognitive Impairment
Cognitive Interventions for Mild Cognitive Impairment Kelly Murphy, PhD Neuropsychology & Cognitive Health, Baycrest Health Sciences Psychology Department, University of Toronto Aging & Speech Communication:
Alzheimer s disease. What is Alzheimer s disease?
Alzheimer s disease What is Alzheimer s disease? What we know about dementia and Alzheimer s disease Alzheimer s disease is the most common of a large group of disorders known as dementias. It is an irreversible
Alzheimer s & Dementia 7 (2011) 280 292
Alzheimer s & Dementia 7 (2011) 280 292 Toward defining the preclinical stages of Alzheimer s disease: Recommendations from the National Institute on Aging-Alzheimer s Association workgroups on diagnostic
WMS III to WMS IV: Rationale for Change
Pearson Clinical Assessment 19500 Bulverde Rd San Antonio, TX, 28759 Telephone: 800 627 7271 www.pearsonassessments.com WMS III to WMS IV: Rationale for Change Since the publication of the Wechsler Memory
GOING BEYOND RISK REDUCTION: PHYSICAL EXERCISE MAY BE AN EFFECTIVE TREATMENT FOR ALZHEIMER S DISEASE AND VASCULAR DEMENTIA
CONTACT: Alzheimer s Association AAIC newsroom, 202-249-4002, [email protected] Niles Frantz, Alzheimer s Association, 312-335-5777, [email protected] GOING BEYOND RISK REDUCTION: PHYSICAL EXERCISE MAY
Normal and Abnormal Aging and the Brain. Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD
Normal and Abnormal Aging and the Brain Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD The myth of cognitive decline The myth of cognitive decline Individual change varies Individual change varies
Social Security Disability Insurance and young onset dementia: A guide for employers and employees
Social Security Disability Insurance and young onset dementia: A guide for employers and employees What is Social Security Disability Insurance? Social Security Disability Insurance (SSDI) is a payroll
Bedside cognitive examination beyond the MMSE. Dr Richard Perry Dept of Neurosciences Imperial College
Bedside cognitive examination beyond the MMSE Dr Richard Perry Dept of Neurosciences Imperial College Overview Initial observations Cognitive rating scales Assessing cognitive domains Memory Language Visuospatial
ANXIETY & COGNITIVE IMPAIRMENT
ANXIETY & COGNITIVE IMPAIRMENT Dr. Sherri Hayden, Ph.D., R. Psych. Neuropsychologist, UBC Hospital Clinic for Alzheimer Disease & Related Disorders Clinical Assistant Professor, UBC Department of Medicine,
Retinal Imaging Biomarkers for Early Diagnosis of Alzheimer s Disease
Retinal Imaging Biomarkers for Early Diagnosis of Alzheimer s Disease Eleonora (Nora) Lad, MD, PhD Assistant Professor of Ophthalmology, Vitreoretinal diseases Duke Center for Macular Diseases Duke University
Automatic Morphological Analysis of the Medial Temporal Lobe
Automatic Morphological Analysis of the Medial Temporal Lobe Neuroimaging analysis applied to the diagnosis and prognosis of the Alzheimer s disease. Andrea Chincarini, INFN Genova Clinical aspects of
Clinical Research Infrastructure
Clinical Research Infrastructure Enhancing UK s Clinical Research Capabilities & Technologies At least 150m to establish /develop cutting-edge technological infrastructure, UK wide. to bring into practice
Prediction of the MoCA and the MMSE in Out-patients with the risks of cognitive impairment
Prediction of the MoCA and the MMSE in Out-patients with the risks of cognitive impairment Teresa Leung Therapist Prince of Wales Hospital 7 th May, 2012 Outline of Presentation Introduction Study Objectives,
Gene E. Alexander, Ph.D. Elsa Baena
Gene E. Alexander, Ph.D. Professor and Director, Brain Imaging Behavior & Aging Lab Department of Psychology and Phone: 520-626-1704 Email: [email protected] Dr. Alexander s research interests
Dementia: Delivering the Diagnosis
Dementia: Delivering the Diagnosis Daniel D. Christensen, M.D. Clinical Professor of Psychiatry Clinical Professor of Neurology Adjunct Professor of Pharmacology University of Utah Diagnosing Dementia
Brain Structures That are Involved with Memory
Early Theories of Brain Structures That are Involved with Psychology 372 Sensation Sensory Attention Rehearsal STM Storage Retrieval Physiological Psychology Steven E. Meier, Ph.D. Listen to the audio
Predicting the future progression of dementia. Ashish Raj, PhD
Business Presentation Predicting the future progression of dementia Ashish Raj, PhD Founder and CEO Associate Professor of Computer Science in Radiology Director, IDEAL Laboratory Associate Professor of
AQT-D. A Quick Test of Cognitive Speed. AQT-D is designed for dementia screening.
AQT-D A Quick Test of Cognitive Speed AQT-D is designed for dementia screening. A General Introduction to AQT AQT 1 is an objective, reliable and standardized screening test designed to measure cognitive
Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE
Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE L Ignoto, il Mistero, stimolano il pensiero, sono indispensabili al poeta ed all artista, aprono alla creatività. L Ignoto, il Mistero,
Copywrite - Eric Freitag, Psy.D., 2012
Diagnosis, Intervention and Care for Patients With Cognitive Impairment Eric J. Freitag, Psy.D, FACPN Diplomate, American College of Professional Neuropsychology Mt. Diablo Memory Center Founder/Executive
The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia
The Role of Neuropsychological Testing in Guiding Decision- Making Related to Dementia By Scott Knight, Director, SLR Diagnostics & Assessments, a division of Sibley & Associates Inc., and Konstantine
Collaborative Care for Alzheimer s Disease
The Health Care Workforce for Older Americans: Promoting Team Care Institute of Medicine Symposium October 2008 Collaborative Care for Alzheimer s Disease Christopher M. Callahan, MD Cornelius and Yvonne
Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW
Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Diagnosis of Dementia : DSM-IV criteria Loss of memory and one or more other cognitive abilities Aphasia Apraxia Agnosia
2016 Programs & Information
Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia
COGNITION IN AGING AND AGE-RELATED DISEASE
COGNITION IN AGING AND AGE-RELATED DISEASE Elizabeth A. Kensinger Department of Psychology Boston College Address correspondence to: Elizabeth A. Kensinger Department of Psychology, McGuinn Hall Boston
Neuropsychology Research Program: Thomas P. Ross, Ph.D.
Neuropsychology Research Program: Thomas P. Ross, Ph.D. My primary research program is devoted to the psychometric examination of neuropsychological tests of executive functioning, and other abilities
Alzheimer s & Dementia 9 (2013) e1 e16
Alzheimer s & Dementia 9 (2013) e1 e16 Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer s Association
2 Neurons. 4 The Brain: Cortex
1 Neuroscience 2 Neurons output integration axon cell body, membrane potential Frontal planning control auditory episodes soma motor Temporal Parietal action language objects space vision Occipital inputs
CONTE Summer Lab Experience Application
CONTE Summer Lab Experience Application When preparing your application for funding from the CONTE Summer Lab Experience through the Undergraduate Program in Neuroscience, please read these instructions
Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease.
Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Memory loss and changes in mood and behavior are some signs that you or a family member may have Alzheimer s disease. If you have
Guidance for Industry Alzheimer s Disease: Developing Drugs for the Treatment of Early Stage Disease
Guidance for Industry Alzheimer s Disease: Developing Drugs for the Treatment of Early Stage Disease DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions
DOTT. GIOVANNI CARLESIMO ELENCO DELLE PUBBLICAZIONI ANNI 2008-2013
DOTT. GIOVANNI CARLESIMO ELENCO DELLE PUBBLICAZIONI ANNI 2008-2013 1. P. Turriziani, M. Oliveri, S. Salerno, F. Costanzo, G. Koch, C. Caltagirone, G. A. Carlesimo. Recognition memory and prefrontal cortex:
Attention, memory and learning and acquired brain injury. Vicki Anderson. Jamie M. Attention & learning: an information processing model
Attention, memory and learning and acquired brain injury Vicki Anderson Jamie M. Childhood acquired amnesia Attention & learning: an information processing model MANAGEMENT Organising, problem solving
Diagnosis and Initial Management of Cognitive Disorders
Diagnosis and Initial Management of Cognitive Disorders January 29, 2016 Kelly Garrett, PhD Cathleen Obray, MD, MHS Neurosciences Clinical Program Cognitive Care Team None Disclosures Neurosciences Clinical
Frequently Asked Questions
Frequently Asked Questions Business Office: 598 Airport Boulevard Suite 1400 Morrisville NC 27560 Contact: [email protected] Phone: 888.750.6941 Fax: 888.650.6795 www.cognitrax.com Diseases of the
Applied Nursing Research
Applied Nursing Research 26 (2013) 71 75 Contents lists available at SciVerse ScienceDirect Applied Nursing Research journal homepage: www.elsevier.com/locate/apnr Clinical Methods Impact of missing data
Simposio Internacional: International Symposium Murray Grossman
Murray Grossman Office Address: Department of Neurology - Gates 3 Hospital of the University of Pennsylvania Philadelphia, PA 19104-4283 If you are not a U.S. citizen please indicate the type of visa you
THEORIES OF NEUROLOGICAL AGING AND DEMENTIA
THEORIES OF NEUROLOGICAL AGING AND DEMENTIA Aging Overview The primary care physician must advise middle-age and older patients about ways to age successfully. Dementia is a common disabling illness that
How To Navigate Early-Stage Alzheimer s Disease
How To Navigate Early-Stage Alzheimer s Disease PRODUCED BY What We Can Expect Unless there is a cure, over the next 20 years, as Baby Boomers turn 65, the age after which Alzheimer s disease becomes most
FUNCTIONAL EEG ANALYZE IN AUTISM. Dr. Plamen Dimitrov
FUNCTIONAL EEG ANALYZE IN AUTISM Dr. Plamen Dimitrov Preamble Autism or Autistic Spectrum Disorders (ASD) is a mental developmental disorder, manifested in the early childhood and is characterized by qualitative
Attention & Memory Deficits in TBI Patients. An Overview
Attention & Memory Deficits in TBI Patients An Overview References Chan, R., et.al.. (2003). Are there sub-types of attentional deficits in patients with persisting post- concussive symptoms? A cluster
Chemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015
Chemobrain Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Terminology Chemotherapy-associated cognitive dysfunction Post-chemotherapy cognitive impairment Cancer treatment-associated cognitive
1 st December 2009. Cardiff Crown Court. Dear. Claimant: Maurice Kirk Date of Birth: 12 th March 1945
Ref: PMK/MT 1 st December 2009 Cardiff Crown Court Dear Claimant: Maurice Kirk Date of Birth: 12 th March 1945 I have been instructed by Yorkshire Law Solicitors to comment on the SPECT scan images undertaken
Appropriate Use of CPT Coding in Treatment of Persons with Memory Impairment
Appropriate Use of CPT Coding in Treatment of Persons with Memory Impairment Cameron J. Camp, Ph.D. Director of Research and Development Center for Applied Research in Dementia [email protected] www.cen4ard.com
Pradeep Redddy Raamana
Pradeep Redddy Raamana Research Scientist at Simon Fraser University [email protected] Summary Highlights 8 years of experience in machine learning, data mining and statistical modelling. 6 years of experience
Scandinavian Bio-Business Seminar, Zürich. Presentation 10 February 2016 Håkon Sæterøy, CEO
Scandinavian Bio-Business Seminar, Zürich Presentation 10 February 2016 Håkon Sæterøy, CEO Clinical need 75 m patients WW A global estimate of 75m patients with Mild Cognitive Impairment (MCI) who may
Alzheimer s and Depression: What is the Connection?
Alzheimer s and Depression: What is the Connection? Ladson Hinton MD Professor and Director of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Director, Education Core, Alzheimer
WISC IV and Children s Memory Scale
TECHNICAL REPORT #5 WISC IV and Children s Memory Scale Lisa W. Drozdick James Holdnack Eric Rolfhus Larry Weiss Assessment of declarative memory functions is an important component of neuropsychological,
Overview. Neuropsychological Assessment in Stroke. Why a Neuropsychologist. How to make a referral. Referral Questions 11/6/2013
Overview Neuropsychological Assessment in Stroke Brandon Ally, PhD Department of Neurology What is Neuropsychology Stroke Specific Neuropsychology Neuropsychological Domains Case Study What is Neuropsychology?
No Dementia Stage 2: Very Mild Cognitive Decline
Stages of Dementia Health professionals sometimes discuss dementia in "stages," which refers to how far a person's dementia has progressed. Defining a person's disease stage helps physicians determine
Mental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault [email protected]
Mental health issues in the elderly January 28th 2008 Presented by Éric R. Thériault [email protected] Cognitive Disorders Outline Dementia (294.xx) Dementia of the Alzheimer's Type (early and late
Local Clinical Trials
Local Clinical Trials The Alzheimer s Association, Connecticut Chapter does not officially endorse any specific research study. The following information regarding clinical trials is provided as a service
Disclosures. Case: Ms. K. Case: Ms. K. Dementia: Considering When to Start, Stop, and Continue Medications 4/23/15. * Nothing to disclose
Dementia: Considering When to Start, Stop, and Continue Medications * Nothing to disclose Disclosures Lianne Hirano, MD UW Division of Gerontology & Geriatric Medicine 4/23/15 Current Concepts in Drug
Dementia Causes and Neuropsychological Evaluation of the Older Adult
Dementia Causes and Neuropsychological Evaluation of the Older Adult Laurie N. Culp, Ph.D. Pate and Culp Psychological Assoc. 2440 Lawrenceville Highway Suite 200 Decatur, GA 30033 678-595-0062 [email protected]
Early Changes in the Brain Proteome Associated with Alzheimer's Disease Risk
Early Changes in the Brain Proteome Associated with Alzheimer's Disease Risk Nicholas T. Seyfried Assistant Professor Departments of Biochemistry and Neurology Alzheimer s Disease Research Center Emory
Auditory memory and cerebral reorganization in post-linguistically deaf adults
Auditory memory and cerebral reorganization in post-linguistically deaf adults Implications for cochlear implantation outcome D Lazard, HJ Lee, E Truy, AL Giraud Ecole Normale Supérieure, Inserm U960,
Cognitive Neuroscience. Questions. Multiple Methods. Electrophysiology. Multiple Methods. Approaches to Thinking about the Mind
Cognitive Neuroscience Approaches to Thinking about the Mind Cognitive Neuroscience Evolutionary Approach Sept 20-22, 2004 Interdisciplinary approach Rapidly changing How does the brain enable cognition?
Encyclopedia of School Psychology Neuropsychological Assessment
Encyclopedia of School Psychology Neuropsychological Assessment Contributors: Cynthia A. Riccio & Kelly Pizzitola Jarratt Edited by: Steven W. Lee Book Title: Encyclopedia of School Psychology Chapter
advancing magnetic resonance imaging and medical data analysis
advancing magnetic resonance imaging and medical data analysis INFN - CSN5 CdS - Luglio 2015 Sezione di Genova 2015-2017 objectives Image reconstruction, artifacts and noise management O.1 Components RF
Staging and Treatment of Dementia
Staging and Treatment of Dementia Ami Hall DO 10/25/14 1 Objectives What are the two most common types of dementias seen in a primary care office How are they staged What treatments are available Definition
In conjunction with clinical history, structural
A QUICK GUIDE FOR NEUROIMAGING OF COMMON DEMENTIAS SEEN IN CLINICAL PRACTICE PRINT THIS ARTICLE David F. Tang-Wai, MDCM, FRCPC, assistant professor of neurology and geriatric medicine at the University
